참고문헌
- Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007;109:8-14.
- Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and metaanalysis. Dev Med Child Neurol 2013;55:509-19. https://doi.org/10.1111/dmcn.12080
- Henderson RC, Kairalla J, Abbas A, Stevenson RD. Predicting low bone density in children and young adults with quadriplegic cerebral palsy. Dev Med Child Neurol 2004;46:416-9.
- Stevenson RD, Conaway M, Barrington JW, Cuthill SL, Worley G, Henderson RC. Fracture rate in children with cerebral palsy. Pediatr Rehabil 2006;9:396-403. https://doi.org/10.1080/13638490600668061
- Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr 2002;141:644-51. https://doi.org/10.1067/mpd.2002.128207
- Crothers B, Paine RS. The natural history of cerebral palsy. London: Mac Keith Press, 1988 (Classics in developmental medicine No. 2).
- Pack AM. Bone disease in epilepsy. Curr Neurol Neurosci Rep 2004;4:329-34. https://doi.org/10.1007/s11910-004-0060-2
- Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract 2006;12:436-45. https://doi.org/10.4158/EP.12.4.436
- Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330-7. https://doi.org/10.1111/j.0013-9580.2004.18804.x
- Zaffuto-Sforza CD. Aging with cerebral palsy. Phys Med Rehabil Clin N Am 2005;16:235-49. https://doi.org/10.1016/j.pmr.2004.06.014
- Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. J Clin Invest 1996;97:2692-6. https://doi.org/10.1172/JCI118722
- Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 2008;11:22-8. https://doi.org/10.1016/j.jocd.2007.12.003
- Southard RN, Morris JD, Mahan JD, Hayes JR, Torch MA, Sommer A, et al. Bone mass in healthy children: measurement with quantitative DXA. Radiology 1991;179:735-8. https://doi.org/10.1148/radiology.179.3.2027984
- Plotkin H, Coughlin S, Kreikemeier R, Heldt K, Bruzoni M, Lerner G. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Dev Med Child Neurol 2006;48:709-12. https://doi.org/10.1017/S0012162206001526
- Bachrach LK, Ward LM. Clinical review 1: bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 2009;94:400-9. https://doi.org/10.1210/jc.2008-1531
- Grissom LE, Kecskemethy HH, Bachrach SJ, McKay C, Harcke HT. Bone densitometry in pediatric patients treated with pamidronate. Pediatr Radiol 2005;35:511-7. https://doi.org/10.1007/s00247-004-1393-3
- Allington N, Vivegnis D, Gerard P. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. Acta Orthop Belg 2005;71:91-7.
- Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, et al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000;85:1846-50.
- Bachrach SJ, Kecskemethy HH, Harcke HT, Hossain J. Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy. Dev Med Child Neurol 2010;52:837-42. https://doi.org/10.1111/j.1469-8749.2010.03676.x
- Al Muderis M, Azzopardi T, Cundy P. Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am 2007;89:1511-6.
- Harcke HT, Stevenson KL, Kecskemethy HH, Bachrach SJ, Grissom LE. Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers. Pediatr Radiol 2012;42:76-81. https://doi.org/10.1007/s00247-011-2198-9
- Presedo A, Dabney KW, Miller F. Fractures in patients with cerebral palsy. J Pediatr Orthop 2007;27:147-53. https://doi.org/10.1097/BPO.0b013e3180317403
- Ott SM. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 2005;90:1897-9. https://doi.org/10.1210/jc.2005-0057
- Lee J, Yoon J, Lee YA, Lim JS, Shin CH, Yang SW. Pamidronate therapy in children and adolescents with secondary osteoporosis. Korean Soc Pediatr Endocrinol 2011;16:178-84. https://doi.org/10.6065/jkspe.2011.16.3.178
피인용 문헌
- Do Bisphosphonates Alleviate Pain in Children? A Systematic Review vol.18, pp.5, 2017, https://doi.org/10.1007/s11914-020-00621-3
- Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents vol.26, pp.2, 2017, https://doi.org/10.6065/apem.2040150.075